Pharm Tech Agenda 2015.08.12
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Meeting details
Wednesday, 12 August 2015, 15:00 CET/CEST
WebEx details:
Meeting number: 954 257 460
JOIN BY PHONE
+33 17091 8646 France toll
0800-9-19312 France toll free
Call-in Numbers: Global Call-in numbers
Access code: 954 257 460
Agenda
- Recap from last webex
- Relevant updates from FHIR
- Continuing the discussion - Goal is to reach a point where we can start to define actors and start checking the FHIR resources and determine if it is consistent with HMW / CMPD.
Recap from last webex:
- We agreed with a few aspects in the model outlined in the PPT:
- Medication "Ordering" is a set of activities that we may aggregate for consistency (We may use a single type of resource for these activities). It includes:
- Planning (e.g. "draft" prescription),
- Prescribing
- ... or other ordering that is the same as prescribing? Like a nurse's "prescription"?
- Order review?
- "Order Review" may be a better candidate than "Pharmaceutical Advice".
- "Medication Dispense" may include several activities. At this moment we are not making a distinction.
- Administration actor may be best called Administration Performer
- Out of the discussion were:
- * "Prescription Management" - the mechanisms to enable that a prescription can be understood as "valid for dispense" etc. are at this moment left out of the discussion. Maybe in or out of scope - that is not decided yet.
- ADE Reporting and post-administration events.
- Medication Statements by a patient
- Medication Lists
- Medication Catalog - how different actors are prepared to share names and attributes of medications.
- Supply aspects other than the dispensing
Relevant updates on FHIR:
- Medication Prescription is being renamed to MedicationOrder
- This is compatible with the suggestion to use one single resource for different orders.
- Prescription statuses are beign discussed - Prescription order status changes like "draft" or "entered in error", and NOT overall workflow status like "completed".
- Identification of medication has been reviewed.
Next
Questions:
- Scope: This being for FHIR, do we want to stick to a scope (e.g. in-country) or prepare for cross-country?
- Decision: The profile should be prepared for the scope of CMPD and HMW; we shall not focus on the specifics to make it e.g. cross-country (e.g. translation or conversion of medication codes/names for cross-country dispense, etc.).